Pages that link to "Q27001897"

The following pages link to Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infection (Q27001897):

Displaying 9 items.

• E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells (Q36078930) ‎ (← links)
• Methylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually (Q36173746) ‎ (← links)
• Oral Immunization with Recombinant Vaccinia Virus Prime and Intramuscular Protein Boost Provides Protection against Intrarectal Simian-Human Immunodeficiency Virus Challenge in Macaques (Q36665647) ‎ (← links)
• First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens (Q37578465) ‎ (← links)
• Vector order determines protection against pathogenic simian immunodeficiency virus infection in a triple component vaccine by balancing CD4+ and CD8+ T-cell responses (Q40042419) ‎ (← links)
• Recent developments in nanocarrier-aided mucosal vaccination (Q40228907) ‎ (← links)
• Recombinant-attenuated Salmonella pullorum strain expressing the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) protects chickens against NDV and Salmonella Pullorum challenge (Q45326330) ‎ (← links)
• Oral immunization of a non-recombinant Lactococcus lactis surface displaying influenza hemagglutinin 1 (HA1) induces mucosal immunity in mice. (Q45391504) ‎ (← links)
• Site-Specific DC Surface Signatures Influence CD4+ T Cell Co-stimulation and Lung-Homing (Q92511254) ‎ (← links)